People Background Check
Find People:

Kenneth D Greis7 Greene St, Newport, KY 41075

Get Report
Known as:
Ken Greis Kenneth Donald Greis K Greis

Kenneth Greis Phones & Addresses

7 Greene St, Fort Thomas, KY 41075 (859) 442-5249

Birmingham, AL

Ann Arbor, MI

Parkville, MD

7 Greene St, Fort Thomas, KY 41075

Work

Position: Service Occupations

Mentions for Kenneth D Greis

Kenneth Greis resumes & CV records

Resumes

Kenneth Greis Photo 6

Associate Professor At University Of Cincinnati

Location:
Cincinnati Area
Industry:
Research
Kenneth Greis Photo 7

Associate Professor At University Of Cincinnati

Location:
Cincinnati Area
Industry:
Biotechnology

Publications & IP owners

Us Patents

Prolyl Hydroxylase Inhibitors And Methods Of Use

US Patent:
8323671, Dec 4, 2012
Filed:
Aug 20, 2010
Appl. No.:
12/860136
Inventors:
Shengde Wu - Wester Chester OH, US
Namal C. Warshakoon - Mason OH, US
Artem G. Evdokimov - Niantic CT, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Richard Masaru Kawamoto - Divide CO, US
Assignee:
Akebia Therapeutics Inc. - Cincinnati OH
International Classification:
A61K 8/02
A61K 31/44
C07D 213/65
C07D 213/89
US Classification:
424401, 514346, 546296, 546298
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Prolyl Hydroxylase Inhibitors And Methods Of Use

US Patent:
8343952, Jan 1, 2013
Filed:
Aug 20, 2010
Appl. No.:
12/860073
Inventors:
Shengde Wu - Wester Chester OH, US
Namal C. Warshakoon - Mason OH, US
Artem G. Evdokimov - Niantic CT, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Richard Masaru Kawamoto - Divide CO, US
Assignee:
Akebia Therapeutics Inc. - Cincinnati OH
International Classification:
A61K 31/4418
A61K 31/4439
A61K 31/444
A61K 31/506
A61K 31/4725
A61K 31/4427
A61K 31/4433
C07D 213/81
C07D 401/10
C07D 401/04
C07D 405/10
A61P 17/02
A61P 7/06
US Classification:
51421018, 514346, 514343, 514340, 514334, 514256, 514307, 514342, 514338, 546291, 5462791, 5462684, 546257, 546144, 5462704, 5462824
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Prolyl Hydroxylase Inhibitors And Methods Of Use

US Patent:
8598210, Dec 3, 2013
Filed:
Nov 20, 2012
Appl. No.:
13/681876
Inventors:
Shengde Wu - West Chester OH, US
Namal C. Warshakoon - Cary NC, US
Artem G. Evdokimov - Foristell MO, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Assignee:
Akebia Therapeutics, Inc. - Cincinnati OH
International Classification:
A01N 43/40
A61K 31/44
C07D 213/62
C07D 213/78
C07D 405/00
US Classification:
514338, 514350, 546298, 5462824
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Angiogenesis Modulating Proteins

US Patent:
2003016, Aug 28, 2003
Filed:
Dec 10, 2002
Appl. No.:
10/316253
Inventors:
Kevin Peters - Loveland OH, US
Larry Thompson - Anderson IN, US
Feng Wang - Cincinnati OH, US
Kenneth Greis - Fort Thomas KY, US
Assignee:
The Procter & Gamble Company
International Classification:
A61K039/395
A61K038/17
US Classification:
514/012000
Abstract:
Angiogenesis modulating proteins may be useful for treating angiogenesis mediated disorders. Further, these angiogenesis modulating proteins may be useful to screen agents that are, in turn, useful for treating angiogenesis mediated disorders.

Prolyl Hydroxylase Inhibitors And Method Of Use

US Patent:
2013024, Sep 19, 2013
Filed:
Apr 9, 2013
Appl. No.:
13/859574
Inventors:
Shengde Wu - West Chester OH, US
Artem G. Evdokimov - Foristell MO, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Namal C. Warshakoon - Cary NC, US
Assignee:
Akebia Therapeutics Inc. - Cincinnati OH
Aerpio Therapeutics Inc. - Cincinnati OH
International Classification:
C07D 213/81
US Classification:
514350, 546298
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Prolyl Hydroxylase Inhibitors And Methods Of Use

US Patent:
2014004, Feb 13, 2014
Filed:
Oct 24, 2013
Appl. No.:
14/062011
Inventors:
Shengde Wu - West Chester OH, US
Artem G. Evdokimov - Foristell MO, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Namal C. Warshakoon - Cary NC, US
Assignee:
Akebia Therapeutics, Inc. - Cincinnati OH
International Classification:
C07D 213/81
C07D 405/04
US Classification:
514338, 514346
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Prolyl Hydroxylase Inhibitors And Methods Of Use

US Patent:
2014005, Feb 27, 2014
Filed:
Nov 4, 2013
Appl. No.:
14/071088
Inventors:
Shengde Wu - West Chester OH, US
Artem G. Evdokimov - Foristell MO, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Namal C. Warshakoon - Cary NC, US
Assignee:
Akebia Therapeutics, Inc. - Cincinnati OH
International Classification:
C07D 417/04
C07D 401/04
C07D 401/10
C07D 213/81
C07D 295/192
US Classification:
51421018, 514350, 514343, 514340, 514334, 514256, 514307, 514342
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD) heart failure, ischemia, and anemia.

Prolyl Hydroxylase Inhibitors And Methods Of Use

US Patent:
7811595, Oct 12, 2010
Filed:
Jun 26, 2007
Appl. No.:
11/821936
Inventors:
Richard Masaru Kawamoto - Divide CO, US
Shengde Wu - Wester Chester OH, US
Namal C. Warshakoon - Mason OH, US
Artem G. Evdokimov - Niantic CT, US
Kenneth D. Greis - Fort Thomas KY, US
Angelique Sun Boyer - West Chester OH, US
Assignee:
Warner Chilcott Company, LLC - Pajardo PR
International Classification:
A61K 8/02
A61K 31/44
C07D 213/65
C07D 213/89
US Classification:
424401, 514346, 546296, 546298
Abstract:
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.

Possible Relatives

Michael J Greis  Kenneth J Stanfill  Kenneth C Stange  Kenneth M Stanger  Kenneth H Stannard  Kenneth R Starcher  Kenneth L Stark  Kenneth Starling  Kenneth D Staub  Kenneth E Stauffer 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.